(Q82669504)
Statements
IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still's disease (English)
L Naumann
E Feist
A Natusch
S Langen
A Krause
F Buttgereit
scientific article published on 01 February 2010